78 results on '"Kiemeney, L.A.L.M."'
Search Results
2. Prognosis of primary papillary Ta-G3 bladder cancer in the non-muscle invasive spectrum
3. Overall survival of patients receiving cisplatin or carboplatin for primary metastatic urothelial carcinoma of the bladder: A contemporary Dutch nationwide cohort study
4. Characteristics and survival of untreated versus treated patients with non-metastatic muscle invasive bladder cancer
5. Meta-analysis of six genome-wide association studies identifies novel loci associated with recurrence and progression of non-muscle invasive bladder cancer
6. Bladder cancer survival: Women only fare worse in the first two years after diagnosis
7. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019?
8. Survival differences between men and women with bladder cancer depend strongly on time since diagnosis
9. Health-related quality of life in non-muscle invasive bladder cancer patients: Comparison to a normative population and changes after diagnosis
10. Low awareness, adherence and practice but positive attitudes regarding lifestyle recommendations among bladder cancer patients
11. Kinome profiling to predict sunitinib response of patients with metastasized clear cell Renal Cell Carcinoma
12. Risk factors for second primary melanoma among Dutch patients with melanoma
13. Hormonale en reproductieve factoren in de ontwikkeling van blaaskanker
14. 24 Laagpenetrante genetische prostaatkankermarkers bij erfelijk prostaatkanker: geen verschillen tussen erfelijk en sporadisch prostaatkanker
15. 29 De toegevoegde waarde van de PCA3-urinetest bij prostaatkankerscreening middels PSA bij mannen met een BRCAmutatie
16. Impact of mitotic activity on the pathological substaging of pT1 cutaneous melanoma
17. Postprostatectomy ultrasound-guided transrectal implantation of gold markers for external beam radiotherapy
18. Risk of prostate cancer among cancer survivors in the Netherlands
19. New insights into the aetiology of scrotal cancer, a nationwide case-control study in the Netherlands
20. DNA adducts in skin biopsies and 1-hydroxypyrene in urine of psoriasis patients and healthy volunteers following treatment with coal tar
21. 324 Invasive Lobular Vs. Ductal Breast Cancer – Patterns of Recurrences Are Dependent On Estrogen Receptor Status
22. 1 Continue versus intermitterende hormonale therapie voor patiënten met gemetastaseerd prostaatcarcinoom
23. 21 Brachytherapie superieur aan open radicale prostatectomie voor low-risk patiënten: vergelijking van 10-jaars resultaten van 1 uroloog
24. 530 RADIAL DISTANCE OF EXTRAPROSTATIC EXTENSION CORRELATES WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
25. 321 RISK OF SECOND PRIMARY CANCERS AFTER URINARY BLADDER CANCER: AN ANALYSIS OF THE NETHERLANDS CANCER REGISTRY
26. 1033 LATE RELAPSE OF TESTICULAR GERM CELL TUMOURS IN 2.729 PATIENTS: A MULTICENTRE ANALYSIS
27. Prostate cancer: Trends in incidence, survival and mortality in the Netherlands, 1989–2006
28. 7101 Risk of metachronous contralateral testicular cancer (CTC) among 3,745 Dutch men diagnosed during 1965–1995
29. 628 THE LENGTH OF POSITIVE SURGICAL MARGINS CORRELATES WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY
30. BLADDER CANCER RECURRENCES CANNOT BE DETECTED IN URINE USING A SNP ARRAY
31. Testicular cancer: Trends in mortality are well explained by changes in treatment and survival in the southern Netherlands since 1970
32. Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study
33. Clinical efficacy of a new 30-min algorithm for transurethral microwave thermotherapy: initial results
34. Prognostic Value of p53 for High Risk Superficial Bladder Cancer With Long-Term Followup
35. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer
36. Current Practice in the Management of Superficial Bladder Cancer in the Netherlands and Belgian Flanders: A Survey
37. Post-Void Residual Urine Volume is Not a Good Predictor of the Need for Invasive Therapy Among Patients With Benign Prostatic Hyperplasia
38. Urinary NMP22® BladderChek® Test in the Diagnosis of Superficial Bladder Cancer
39. Hypospadias: a transgenerational effect of diethylstilbestrol?
40. Prognostic factors for a subsequent basal cell carcinoma: implications for follow-up
41. Does the Tertiary Gleason Pattern Influence the PSA Progression-Free Interval after Retropubic Radical Prostatectomy for Organ-Confined Prostate Cancer?
42. Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting
43. 646 The impact of different follow-up strategies on mortality in clinical stage I non-seminomatous germ cell cancer. A semi-Markov simulation study
44. Prostate-Specific Antigen as an Estimator of Prostate Volume in the Management of Patients with Symptomatic Benign Prostatic Hyperplasia
45. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis
46. Prognosis of muscle-invasive bladder cancer, differences between de novo and progressive patients
47. Posterior tibial nerve stimulation in the treatment of overactive bladder and voiding dysfunction: Urodynamic data
48. The increased risk of surgery by PSA and prostate volume: Alfa- blocker and watchful waiting patients from real life clinical practice
49. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure
50. Difference in stage and morphology-adjusted survival between young and elderly patients with a testicular germ cell tumor
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.